Statin use differs among Hispanic adults at risk for heart disease
American Heart Association Rapid Access Journal Report
- In the United States, adults of different Hispanic or Latino backgrounds who are at high risk for heart disease, varied significantly in their use of cholesterol-lowering medications known as statins.
- Statin use was highest among U.S. adults of Puerto Rican or Dominican heritage and lowest among those of Central American background.
- The difference in statin use depended upon whether study participants had health insurance.
Embargoed until 3 p.m. CT / 4 p.m. ET Wednesday, March 30, 2016
DALLAS, March 30, 2016 — In the United States, adults of different Hispanic/Latino backgrounds, at high risk for heart disease, varied significantly in their use of widely-prescribed cholesterol-lowering medications known as statins, according to new research in the Journal of the American Heart Association. The difference was based on whether or not they had health insurance.
“These findings have important implications for preventing disparities in cardiovascular outcomes within the growing U.S. Hispanic/Latino population,” said study lead author Dima M. Qato, Pharm.D., M.P.H., Ph.D., assistant professor of pharmacy systems, outcomes and policy at the University of Illinois in Chicago. “Efforts to increase the use of statins, particularly targeting individuals that have already suffered a heart attack or stroke, should include expanding health insurance for all Hispanic/Latino adults that currently lack coverage, regardless of their heritage.”
In one of the first studies to document differences in the use of statins and aspirin among diverse Hispanic/Latino populations in the United States, investigators found statin use was highest among high-risk study participants of Puerto-Rican heritage at 33 percent followed by those of Dominican heritage at 28 percent. The range was 22 percent for participants of Cuban and South American heritage and lowest among those of Central American backgrounds at 20 percent. However, lacking health insurance was associated with a lower likelihood of statin use in all groups.
Results were from 4,139 patients at high risk for heart disease enrolled in the larger Hispanic Community Health Study/Study of Latinos, in the Bronx, New York; Chicago, Illinois; Miami, Florida; and San Diego, California between March 2008 and June 2011. All participants (average age 52, about half women) were at high risk for heart disease, defined in the study as ever having had a heart attack, stroke, or diabetes. At enrollment, participants underwent medical examinations and answered questionnaires about medication use and heart disease history.
Overall, researchers noted that one-fourth of study participants took statins and less than half (44 percent) took aspirin. The use of aspirin (available over-the-counter without a prescription) was comparable among all Hispanic/Latino groups.
“Efforts to improve statin prescribing in patients likely to benefit are particularly important in patients with history of heart disease,” Qato said. “Healthcare providers and policy makers should be aware of the role of insurance in the underuse of preventative cardiovascular medications in specific Hispanic/Latino populations.”
Heart disease is the No. 1 killer for all Americans and stroke is the fifth leading cause of death. Hispanics and Latinos, however, face even higher risks of cardiovascular diseases because of high blood pressure, obesity and diabetes. Lifestyle changes outlined in the American Heart Association’s Life’s Simple 7® — controlling cholesterol, managing blood pressure and blood sugar, getting active, eating better, losing weight, and quitting smoking—can help lower these risks. But when lifestyle changes are not enough, medication also may be necessary.
Co-authors are Todd A. Lee, Pharm.D, Ph.D.; Ramon Durazo-Arvizu, Ph.D.; Donghong Wu, M.S.; Jocelyn Wilder, M.P.H.; Samantha A. Reina, M.S.; Jianwen Cai, Ph.D.; Franklin Gonzalez II, M.S.; Gregory A Talavera, M.D., M.P.H.; Robert Ostfeld, M.D., M.S. and Martha L. Daviglus M.D., Ph.D.
The National Heart, Lung, and Blood Institute; National Institute on Minority Health and Health Disparities; National Institute on Deafness and Other Communication Disorders; National Institute of Dental and Craniofacial Research; National Institute of Diabetes and Digestive and Kidney Diseases; National Institute of Neurological Disorders and Stroke and the NIH Institution-Office of Dietary Supplements supported the study.
- Researcher photo and cholesterol test images are located in the right column of this release link http://newsroom.heart.org/news/statin-use-differs-among-hispanic-adults-at-risk-for-heart-disease?preview=2a4d6523488b946856dbde11b1a459fd
- After, March 30, 2016, view the manuscript online.
- Link to Spanish release
- Follow AHA/ASA news on Twitter @HeartNews.
- For updates and new science from JAHA, follow @JAHA_AHA.
Statements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association’s policy or position. The association makes no representation or guarantee as to their accuracy or reliability. The association receives funding primarily from individuals; foundations and corporations (including pharmaceutical, device manufacturers and other companies) also make donations and fund specific association programs and events. The association has strict policies to prevent these relationships from influencing the science content. Revenues from pharmaceutical and device corporations are available at www.heart.org/corporatefunding.
For Media Inquiries and AHA/ASA Spokesperson Perspective: (214) 706-1173
Akeem Ranmal: (214) 706-1755; email@example.com
Julie Del Barto (national broadcast): (214) 706-1330; firstname.lastname@example.org
For Public Inquiries: (800)-AHA-USA1 (242-8721)
Life is why, science is how . . . we help people live longer, healthier lives.